肼屈嗪诱发的皮肤血管炎。 - Suppr

Suppr

超能文献

Hydrallazine-induced cutaneous vasculitis.

作者信息

Bernstein R M, Egerton-Vernon J, Webster J

出版信息

Br Med J. 1980 Jan 19;280(6208):156-7. doi: 10.1136/bmj.280.6208.156-a.

DOI:10.1136/bmj.280.6208.156-a

PMID:7357301

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1600356/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dbb/1600356/2ac8e5ce9977/brmedj00003-0025-a.jpg

相似文献

Hydrallazine-induced cutaneous vasculitis.

Br Med J. 1980 Jan 19;280(6208):156-7. doi: 10.1136/bmj.280.6208.156-a.

Hydrallazine-induced necrotising vasculitis.

Br Med J (Clin Res Ed). 1981 May 23;282(6277):1703-4. doi: 10.1136/bmj.282.6277.1703-d.

Hydralazine-induced necrotising vasculitis.

Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1121-2. doi: 10.1136/bmj.282.6270.1121-a.

Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis.

Mod Rheumatol. 2009;19(3):338-47. doi: 10.1007/s10165-009-0168-y. Epub 2009 May 8.

Hydralazine predisposes to acute cutaneous vasculitis following urography with iopamidol.

Br J Dermatol. 1993 Jul;129(1):82-5. doi: 10.1111/j.1365-2133.1993.tb03317.x.

Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.

QJM. 1995 Nov;88(11):775-83.

[Gabapentin-induced cutaneous leukocytoclastic vasculitis].

Therapie. 2014 Sep-Oct;69(5):469-71. doi: 10.2515/therapie/2014034. Epub 2014 Jul 23.

Cutaneous leukocytoclastic vasculitis in relation to streptokinase.

Neth J Med. 1992 Feb;40(1-2):76-9.

Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis.

J Trop Pediatr. 2013 Dec;59(6):507-8. doi: 10.1093/tropej/fmt048. Epub 2013 Jun 18.

Orlistat-induced bullous leukocytoclastic vasculitis.

Cutis. 2013 Mar;91(3):148-9.

引用本文的文献

Drug-Induced Renal Vasculitis: Etiology, Pathogenesis, Clinical Manifestations, and Therapeutic Approaches-A Narrative Review.

Health Sci Rep. 2025 Apr 16;8(4):e70667. doi: 10.1002/hsr2.70667. eCollection 2025 Apr.

Focal Alveolar Hemorrhage Secondary to Hydralazine-Associated Antineutrophilic Cytoplasmic Antibody Vasculitis.

Cureus. 2023 Jul 17;15(7):e42031. doi: 10.7759/cureus.42031. eCollection 2023 Jul.

Hydralazine-induced vasculitis presenting with ocular manifestations.

Am J Ophthalmol Case Rep. 2022 Apr 10;26:101515. doi: 10.1016/j.ajoc.2022.101515. eCollection 2022 Jun.

Severe cutaneous presentation of hydralazine-induced ANCA vasculitis without renal or pulmonary involvement, complicated by DIC.

BMJ Case Rep. 2021 May 11;14(5):e238609. doi: 10.1136/bcr-2020-238609.

Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.

Curr Cardiol Rev. 2021;17(2):182-187. doi: 10.2174/1573403X16666200518092814.

A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis.

Proc (Bayl Univ Med Cent). 2019 Mar 27;32(2):231-234. doi: 10.1080/08998280.2019.1570422. eCollection 2019 Apr.

Outcomes of hydralazine induced renal vasculitis.

Eur J Rheumatol. 2018 Mar;5(1):5-8. doi: 10.5152/eurjrheum.2017.17075. Epub 2017 Dec 7.

Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.

Int Urol Nephrol. 2012 Dec;44(6):1907-9. doi: 10.1007/s11255-011-9989-7. Epub 2011 May 17.

Drug-induced lupus erythematosus: incidence, management and prevention.

Drug Saf. 2011 May 1;34(5):357-74. doi: 10.2165/11588500-000000000-00000.

Hydralazine-induced necrotising vasculitis.

Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1121-2. doi: 10.1136/bmj.282.6270.1121-a.

本文引用的文献

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.

Am J Med. 1973 Jan;54(1):58-72. doi: 10.1016/0002-9343(73)90084-3.

Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.

Acta Med Scand. 1976;200(5):367-71. doi: 10.1111/j.0954-6820.1976.tb08248.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Hydrallazine-induced cutaneous vasculitis.

Br Med J. 1980 Jan 19;280(6208):156-7. doi: 10.1136/bmj.280.6208.156-a.

Hydrallazine-induced necrotising vasculitis.

Br Med J (Clin Res Ed). 1981 May 23;282(6277):1703-4. doi: 10.1136/bmj.282.6277.1703-d.

Hydralazine-induced necrotising vasculitis.

Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1121-2. doi: 10.1136/bmj.282.6270.1121-a.

Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis.

Mod Rheumatol. 2009;19(3):338-47. doi: 10.1007/s10165-009-0168-y. Epub 2009 May 8.

Hydralazine predisposes to acute cutaneous vasculitis following urography with iopamidol.

Br J Dermatol. 1993 Jul;129(1):82-5. doi: 10.1111/j.1365-2133.1993.tb03317.x.

Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.

QJM. 1995 Nov;88(11):775-83.

[Gabapentin-induced cutaneous leukocytoclastic vasculitis].

Therapie. 2014 Sep-Oct;69(5):469-71. doi: 10.2515/therapie/2014034. Epub 2014 Jul 23.

Cutaneous leukocytoclastic vasculitis in relation to streptokinase.

Neth J Med. 1992 Feb;40(1-2):76-9.

Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis.

J Trop Pediatr. 2013 Dec;59(6):507-8. doi: 10.1093/tropej/fmt048. Epub 2013 Jun 18.

Orlistat-induced bullous leukocytoclastic vasculitis.

Cutis. 2013 Mar;91(3):148-9.

引用本文的文献

Drug-Induced Renal Vasculitis: Etiology, Pathogenesis, Clinical Manifestations, and Therapeutic Approaches-A Narrative Review.

Health Sci Rep. 2025 Apr 16;8(4):e70667. doi: 10.1002/hsr2.70667. eCollection 2025 Apr.

Focal Alveolar Hemorrhage Secondary to Hydralazine-Associated Antineutrophilic Cytoplasmic Antibody Vasculitis.

Cureus. 2023 Jul 17;15(7):e42031. doi: 10.7759/cureus.42031. eCollection 2023 Jul.

Hydralazine-induced vasculitis presenting with ocular manifestations.

Am J Ophthalmol Case Rep. 2022 Apr 10;26:101515. doi: 10.1016/j.ajoc.2022.101515. eCollection 2022 Jun.

Severe cutaneous presentation of hydralazine-induced ANCA vasculitis without renal or pulmonary involvement, complicated by DIC.

BMJ Case Rep. 2021 May 11;14(5):e238609. doi: 10.1136/bcr-2020-238609.

Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.

Curr Cardiol Rev. 2021;17(2):182-187. doi: 10.2174/1573403X16666200518092814.

A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis.

Proc (Bayl Univ Med Cent). 2019 Mar 27;32(2):231-234. doi: 10.1080/08998280.2019.1570422. eCollection 2019 Apr.

Outcomes of hydralazine induced renal vasculitis.

Eur J Rheumatol. 2018 Mar;5(1):5-8. doi: 10.5152/eurjrheum.2017.17075. Epub 2017 Dec 7.

Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.

Int Urol Nephrol. 2012 Dec;44(6):1907-9. doi: 10.1007/s11255-011-9989-7. Epub 2011 May 17.

Drug-induced lupus erythematosus: incidence, management and prevention.

Drug Saf. 2011 May 1;34(5):357-74. doi: 10.2165/11588500-000000000-00000.

Hydralazine-induced necrotising vasculitis.

Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1121-2. doi: 10.1136/bmj.282.6270.1121-a.

本文引用的文献

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.

Am J Med. 1973 Jan;54(1):58-72. doi: 10.1016/0002-9343(73)90084-3.

Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.

Acta Med Scand. 1976;200(5):367-71. doi: 10.1111/j.0954-6820.1976.tb08248.x.